美国 · 财经报刊 · Investor's Business Daily
Iovance, A Top 1% Biotech Stock, Crashes In A Surprise Lung Cancer Twist
Iovance stock crashed Thursday, undercutting its 50-day line, on new durability questions for its experimental lung cancer treatment. The post Iovance, A Top 1% Biotech Stock,…
在 Investor's Business Daily 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.investors.com)